Experimental Drug May Prevent Chemotherapy Drug from Damaging the Heart
March 3, 2020—(BRONX, NY)—The commonly used chemotherapy drug doxorubicin can damage heart muscle, in some cases leading to severe or lethal heart failure. A new study led byAlbert Einstein College of Medicine researchers and involving zebrafish and mice suggests that the experimental drug BAI1 can prevent doxorubicin from damaging the heart without lessening its anti-cancer properties. The study was published online in the journalNature Cancer.
Source: Einstein News - Category: Universities & Medical Training Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Heart | Heart Failure | Study | Universities & Medical Training